Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. VBL's lead oncology product candidate, ofranergene obadenovec (VB-111), is a targeted anti-cancer gene-therapy agent that is being developed to treat a wide range of solid tumors. VBL Therapeutics is headquartered in Israel.
View Top Employees from VBL| Website | http://www.vblrx.com |
| Ticker | VBLT |
| Revenue | $585000 |
| Employees | 475 (202 on RocketReach) |
| Founded | 2000 |
| Address | 8 Hasatat St, Modi'in, Central District 7178106, IL |
| Phone | +972 8-993-5000 |
| Fax | +972 8-993-5001 |
| Industry | Food and Beverage Services, Pharmaceuticals, Healthcare |
| Web Rank | 6 Million |
| Keywords | Cancer Treatment, Biopharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies |
Looking for a particular VBL employee's phone or email?
VBL Questions
The VBL annual revenue was $585000 in 2024.
George Victoria is the Business Owner of VBL.
202 people are employed at VBL.
VBL is based in Modi'in, Central District.
The NAICS codes for VBL are [541, 32, 32541, 325, 3254, 54].
The SIC codes for VBL are [28, 80, 283].
Top VBL Employees
-
22
-
1
-
-
1
-
1
-
1
-
Related Companies
